(0.03%) 5 470.99 points
(0.04%) 39 129 points
(0.32%) 17 774 points
(-0.24%) $80.64
(-5.04%) $2.62
(-0.91%) $2 309.60
(-0.39%) $28.76
(3.07%) $1 016.70
(0.35%) $0.936
(0.74%) $10.68
(0.52%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders...
Stats | |
---|---|
Dagens volum | 401 467 |
Gjennomsnittsvolum | 29 535 |
Markedsverdi | 3.02M |
EPS | $1.030 ( Q1 | 2024-05-09 ) |
Neste inntjeningsdato | ( $0 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0266 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.122 (0.74%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-25 | Alloway Paul | Buy | 23 530 | Common Stock |
2024-03-25 | Alloway Paul | Sell | 18 090 | Restricted Stock Units |
2024-03-25 | Michaud Charles Jr | Buy | 6 448 | Common Stock |
2024-03-25 | Michaud Charles Jr | Sell | 5 360 | Restricted Stock Units |
2024-01-01 | Tzianabos Arthur | Buy | 19 140 | Common Stock |
INSIDER POWER |
---|
34.05 |
Last 94 transactions |
Buy: 1 681 707 | Sell: 632 243 |
Homology Medicines Inc Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Homology Medicines Inc Korrelasjon - Valuta/Råvare
Homology Medicines Inc Økonomi
Annual | 2023 |
Omsetning: | $1.16M |
Bruttogevinst: | $578 000 (50.00 %) |
EPS: | $-351.57 |
FY | 2023 |
Omsetning: | $1.16M |
Bruttogevinst: | $578 000 (50.00 %) |
EPS: | $-351.57 |
FY | 2022 |
Omsetning: | $3.21M |
Bruttogevinst: | $609 000 (18.98 %) |
EPS: | $0.00840 |
FY | 2021 |
Omsetning: | $33.97M |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-1.901 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Homology Medicines Inc
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, cardiac and skeletal muscle, and eye. Its lead product candidate is HMI-102, which is in Phase 2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II, as well as HMI-104 for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.